CRN On IMF Screening, NPA On SSCI Audits, New Products: Health And Wellness Industry News
This article was originally published in The Rose Sheet
Executive Summary
Mood Uplift from Gaia Herbs; Chewpod sleep and go gum in US; Arjuna offers ashwagandha extract; CRN urges laerts, recalls from FDA's improved import screening; and NPA-led initiative completes pilot audits.
You may also be interested in...
Ion Spectrometer Improves FDA's Import Screening: Health And Wellness Industry News
FDA implementing ion mobility spectrometer devices for faster import screening; Kratom products recalled in Utah in salmonella investigation; ABC names Low Dog first Kronenberg Award winner; and AHPA revises liability insurance primer.
NPA, Retailers Tackle Accountability: Health & Wellness Industry News Roundup
NPA, retailers tackle farm-to-shelf accountability; Probiotic best practices from CRN, IPA; Born Wild to incubate food, beverage brands; and more news in brief.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.